Sign In
NewsRadar

Search Press
Looking for press releases of a particular company? Enter company name (or keyword) here.

   


Direvo completes laboratory scale development of low cost lactic acid production technology


Cologne, Germany, November 19, 2013. Direvo Industrial Biotechnology GmbH (Direvo) announces the successful completion of laboratory scale development of a fermentation process for low cost production of L-lactic acid, a part of its BluCon® technology platform. The technology platform enables one-step conversion of nonfood biomass to valuable chemicals, for example lactic acid.

Direvo´s CEO Jorg Riesmeier stated, “Our proprietary bacteria ferment grass, straw and other agricultural and forestry wastes. We have improved yield and conversion rate dramatically over the last 18 months. Again, Direvo has proven the ability to rapidly develop novel biotech processes.”

The BluCon® technology offers consolidated bioprocesses for production of biofuels and biobased chemicals. Consolidated bioprocessing is the conversion of lignocellulose into target products in a single step by microorganisms without additional enzymes. BluCon® accepts various non-food biomass ranging from grasses and straw to agricultural and wood residues and can therefore be applied to a wide variety of feedstocks around the globe.

Jorg Riesmeier added, “The investments made so far in proprietary bacteria and processes laid a strong and competitive scientific and technical foundation. Currently, we are evaluating strategic options which will support further development and will bring our process rapidly to market. Further scale-up will establish the most cost effective production process for lactic acid.”

About Direvo Industrial Biotechnology GmbH:
Direvo is a biotechnology company with focus on the biomass conversion industry. Direvo identifies bottlenecks and weaknesses in current industrial processes in this sector and develops and implements biology-based solutions together with large and small industrial partners. Direvo’s products are newly designed enzymes and microorganisms of the highest quality that provide easy-to-implement, cost-effective solutions. Direvo’s contribution assures that partners stay competitive and profitable while supporting them to make the future cleaner, greener and safer. More information about Direvo is available on www.direvo.com.

Contact:
Dr. Jörg Riesmeier
DIREVO Industrial Biotechnology GmbH
Nattermannallee 1
50829 Köln (Cologne)
Germany

Phone +49 221-47448-101
Fax +49 221-47448-111

E-Mail joerg.riesmeier@direvo.com
Internet www.direvo.com


Publisher Contact Information:

DIREVO Industrial Biotechnology GmbH
+49 221-47448-101
joerg.riesmeier@direvo.com

Company profile of DIREVO Industrial Biotechnology GmbH
Past press releases of DIREVO Industrial Biotechnology GmbH.

Data


27,461
Tech investments
From our Online Data Service
17,713
VC-backed companies
From our Radar


Recent Deals


DATEAMOUNTSECTOR
Nov 25€24.0MInternet commerce
Oct 16€11.0MOther Biotechnology & Healthcare
Oct 16€6.3MBiotechnology
Oct 15€4.0MSecurity
Oct 15€25.0MBiotechnology
Oct 15€169.0MOther Communications
Oct 15€4.1MSmart cards

For information on Europe's most extensive database on technology funding click here!

Events



Press Releases


Sep 30
TetaVi
tetavi raises $6 million to help more companies bring 3d holograms ...

May 28
Identiq
identiq raises $5m seed, launches privacy-first identity validation...

Apr 29
Nethone
nethone raised over $1 million from innovation nest

Mar 31
CompPair
the fit allocates chf 100'000 to comppair technologies

Jan 29
Yumpingo
yumpingo raises $10m to transform guest experiences in restaurants





About usContact usLegal Information
Copyright © 1999-2019
Emerging Technology Research Europe Inc. All rights reserved.